Skip to main content
Top
Published in: BMC Medical Genetics 1/2019

Open Access 01-12-2019 | Schizophrenia | Research article

Association between polymorphisms in the GRIN1 gene 5′ regulatory region and schizophrenia in a northern Han Chinese population and haplotype effects on protein expression in vitro

Authors: Yong-ping Liu, Mei Ding, Xi-cen Zhang, Yi Liu, Jin-feng Xuan, Jia-xin Xing, Xi Xia, Jun Yao, Bao-jie Wang

Published in: BMC Medical Genetics | Issue 1/2019

Login to get access

Abstract

Background

Schizophrenia is a severe neurodevelopmental disorder with a complex genetic and environmental etiology. Abnormal glutamate ionotropic N-methyl-D-aspartate receptor (NMDA) type subunit 1 (NR1) may be a potential cause of schizophrenia.

Methods

We conducted a case-control study to investigate the association between the GRIN1 gene, which encodes the NR1 subunit, and the risk of schizophrenia in a northern Chinese Han population using Sanger DNA sequencing. The dual luciferase reporter assay was used to detect the influence of two different haplotypes on GRIN1 gene expression.

Results

Seven SNPs (single nucleotide polymorphisms), including rs112421622 (− 2019 T/C), rs138961287 (− 1962--1961insT), rs117783907 (−1945G/T), rs181682830 (−1934G/A), rs7032504 (-1742C/T), rs144123109 (−1140G/A), and rs11146020 (−855G/C) were detected in the study population. Rs117783907 (−1945G/T) was associated with the occurrence of schizophrenia as a protective factor. The genotype frequencies of rs138961287 (− 1962--1961insT) and rs11146020 (−855G/C) were statistically different between cases and controls (p < 0.0083). The other four variations were not shown to be associated with the disease. Two haplotypes were composed of the seven SNPs, and distribution of T-del-G-G-C-G-G was significantly different between the case and control groups. However, the dual luciferase reporter assay showed that neither of the haplotypes affected luciferase expression in HEK-293 and SK-N-SH cell lines.

Conclusions

The GRIN1 gene may be related to the occurrence of schizophrenia. Additional research will be needed to fully ascertain the role of GRIN1 in the etiology of schizophrenia.
Appendix
Available only for authorised users
Literature
1.
go back to reference Xu Y, Ren J, Ye H. Association between variations in the disrupted in schizophrenia 1 gene and schizophrenia: A meta-analysis. Gene. 2018;651:94–9.CrossRef Xu Y, Ren J, Ye H. Association between variations in the disrupted in schizophrenia 1 gene and schizophrenia: A meta-analysis. Gene. 2018;651:94–9.CrossRef
2.
go back to reference Schizophrenia Working Group of the Psychiatric Genomics C. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511:421–7.CrossRef Schizophrenia Working Group of the Psychiatric Genomics C. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511:421–7.CrossRef
3.
go back to reference Rabacchi S, Bailly Y, Delhaye-Bouchaud N, Mariani J. Involvement of the N-methyl D-aspartate (NMDA) receptor in synapse elimination during cerebellar development. Science. 1992;256:1823–5.CrossRef Rabacchi S, Bailly Y, Delhaye-Bouchaud N, Mariani J. Involvement of the N-methyl D-aspartate (NMDA) receptor in synapse elimination during cerebellar development. Science. 1992;256:1823–5.CrossRef
4.
go back to reference Wood MW, VanDongen HM, VanDongen AM. The 5′-untranslated region of the N-methyl-D-aspartate receptor NR2A subunit controls efficiency of translation. J Biol Chem. 1996;271:8115–20.CrossRef Wood MW, VanDongen HM, VanDongen AM. The 5′-untranslated region of the N-methyl-D-aspartate receptor NR2A subunit controls efficiency of translation. J Biol Chem. 1996;271:8115–20.CrossRef
5.
go back to reference Morris RG. NMDA receptors and memory encoding. Neuropharmacology. 2013;74:32–40.CrossRef Morris RG. NMDA receptors and memory encoding. Neuropharmacology. 2013;74:32–40.CrossRef
6.
go back to reference Hansen KB, Yi F, Perszyk RE, Menniti FS, Traynelis SFNMDA. Receptors in the Central Nervous System. Methods Mol Biol. 2017;1677:1–80.CrossRef Hansen KB, Yi F, Perszyk RE, Menniti FS, Traynelis SFNMDA. Receptors in the Central Nervous System. Methods Mol Biol. 2017;1677:1–80.CrossRef
7.
go back to reference Moghaddam B, Krystal JH. Capturing the angel in “angel dust”: twenty years of translational neuroscience studies of NMDA receptor antagonists in animals and humans. Schizophr Bull. 2012;38:942–9.CrossRef Moghaddam B, Krystal JH. Capturing the angel in “angel dust”: twenty years of translational neuroscience studies of NMDA receptor antagonists in animals and humans. Schizophr Bull. 2012;38:942–9.CrossRef
8.
go back to reference Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry. 1991;148:1301–8.CrossRef Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry. 1991;148:1301–8.CrossRef
9.
go back to reference Zhou Q, Sheng M. NMDA receptors in nervous system diseases. Neuropharmacology. 2013;74:69–75.CrossRef Zhou Q, Sheng M. NMDA receptors in nervous system diseases. Neuropharmacology. 2013;74:69–75.CrossRef
10.
go back to reference Vyklicky V, Korinek M, Smejkalova T, Balik A, Krausova B, Kaniakova M, et al. Structure, function, and pharmacology of NMDA receptor channels. Physiol Res. 2014;63(Suppl 1):S191–203.PubMed Vyklicky V, Korinek M, Smejkalova T, Balik A, Krausova B, Kaniakova M, et al. Structure, function, and pharmacology of NMDA receptor channels. Physiol Res. 2014;63(Suppl 1):S191–203.PubMed
11.
go back to reference Wang H, Wang X, Li Y, Yu H, Wang C, Feng C, et al. Chronic ethanol exposure induces SK-N-SH cell apoptosis by increasing N-methyl-D-aspartic acid receptor expression and intracellular calcium. Exp Ther Med. 2018;15:3791–800.PubMedPubMedCentral Wang H, Wang X, Li Y, Yu H, Wang C, Feng C, et al. Chronic ethanol exposure induces SK-N-SH cell apoptosis by increasing N-methyl-D-aspartic acid receptor expression and intracellular calcium. Exp Ther Med. 2018;15:3791–800.PubMedPubMedCentral
12.
go back to reference Mohn AR, Gainetdinov RR, Caron MG, Koller BH. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell. 1999;98:427–36.CrossRef Mohn AR, Gainetdinov RR, Caron MG, Koller BH. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell. 1999;98:427–36.CrossRef
13.
go back to reference Weickert CS, Fung SJ, Catts VS, Schofield PR, Allen KM, Moore LT, et al. Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia. Mol Psychiatry. 2013;18:1185–92.CrossRef Weickert CS, Fung SJ, Catts VS, Schofield PR, Allen KM, Moore LT, et al. Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia. Mol Psychiatry. 2013;18:1185–92.CrossRef
14.
go back to reference Catts VS, Derminio DS, Hahn CG, Weickert CS. Postsynaptic density levels of the NMDA receptor NR1 subunit and PSD-95 protein in prefrontal cortex from people with schizophrenia. NPJ Schizophr. 2015;1:15037.CrossRef Catts VS, Derminio DS, Hahn CG, Weickert CS. Postsynaptic density levels of the NMDA receptor NR1 subunit and PSD-95 protein in prefrontal cortex from people with schizophrenia. NPJ Schizophr. 2015;1:15037.CrossRef
15.
go back to reference Focking M, Lopez LM, English JA, Dicker P, Wolff A, Brindley E, et al. Proteomic and genomic evidence implicates the postsynaptic density in schizophrenia. Mol Psychiatry. 2015;20:424–32.CrossRef Focking M, Lopez LM, English JA, Dicker P, Wolff A, Brindley E, et al. Proteomic and genomic evidence implicates the postsynaptic density in schizophrenia. Mol Psychiatry. 2015;20:424–32.CrossRef
16.
go back to reference Tani A, Kikuta R, Itoh K, Joo A, Shibata H, Ninomiya H, et al. Polymorphism analysis of the upstream region of the human N-methyl-D-aspartate receptor subunit NR1 gene (GRIN1): implications for schizophrenia. Schizophr Res. 2002;58:83–6.CrossRef Tani A, Kikuta R, Itoh K, Joo A, Shibata H, Ninomiya H, et al. Polymorphism analysis of the upstream region of the human N-methyl-D-aspartate receptor subunit NR1 gene (GRIN1): implications for schizophrenia. Schizophr Res. 2002;58:83–6.CrossRef
17.
go back to reference Hung CC, Chen HY, Chen CH. Systematic mutation analysis of the human glutamate receptor, ionotropic, N-methyl-D-aspartate 1 gene(GRIN1) in schizophrenic patients. Psychiatr Genet. 2002;12:225–30.CrossRef Hung CC, Chen HY, Chen CH. Systematic mutation analysis of the human glutamate receptor, ionotropic, N-methyl-D-aspartate 1 gene(GRIN1) in schizophrenic patients. Psychiatr Genet. 2002;12:225–30.CrossRef
18.
go back to reference Xu FL, Ding M, Yao J, Shi ZS, Wu X, Zhang JJ, et al. Association between mitochondrial DNA variations and schizophrenia in the northern Chinese Han population. PloS one. 2017;12:e0182769.CrossRef Xu FL, Ding M, Yao J, Shi ZS, Wu X, Zhang JJ, et al. Association between mitochondrial DNA variations and schizophrenia in the northern Chinese Han population. PloS one. 2017;12:e0182769.CrossRef
19.
go back to reference Zhao X, Li H, Shi Y, Tang R, Chen W, Liu J, et al. Significant association between the genetic variations in the 5′ end of the N-methyl-D-aspartate receptor subunit gene GRIN1 and schizophrenia. Biol Psychiatry. 2006;59:747–53.CrossRef Zhao X, Li H, Shi Y, Tang R, Chen W, Liu J, et al. Significant association between the genetic variations in the 5′ end of the N-methyl-D-aspartate receptor subunit gene GRIN1 and schizophrenia. Biol Psychiatry. 2006;59:747–53.CrossRef
20.
go back to reference Begni S, Moraschi S, Bignotti S, Fumagalli F, Rillosi L, Perez J, et al. Association between the G1001C polymorphism in the GRIN1 gene promoter region and schizophrenia. Biol Psychiatry. 2003;53:617–9.CrossRef Begni S, Moraschi S, Bignotti S, Fumagalli F, Rillosi L, Perez J, et al. Association between the G1001C polymorphism in the GRIN1 gene promoter region and schizophrenia. Biol Psychiatry. 2003;53:617–9.CrossRef
21.
go back to reference Saadat M. N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) G1001C polymorphism and susceptibility to schizophrenia: A meta-analysis. EXCLI J. 2010;9:11–6.PubMedPubMedCentral Saadat M. N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) G1001C polymorphism and susceptibility to schizophrenia: A meta-analysis. EXCLI J. 2010;9:11–6.PubMedPubMedCentral
22.
go back to reference Zwicker A, Denovan-Wright EM, Uher R. Gene-environment interplay in the etiology of psychosis. Psychol Med. 2018;48:1925–36.CrossRef Zwicker A, Denovan-Wright EM, Uher R. Gene-environment interplay in the etiology of psychosis. Psychol Med. 2018;48:1925–36.CrossRef
23.
go back to reference Lam M. Comparative genetic architectures of schizophrenia in East Asian and European populations; 2018.CrossRef Lam M. Comparative genetic architectures of schizophrenia in East Asian and European populations; 2018.CrossRef
24.
go back to reference Liu X, Qin H, Wu J. Xu J. Association of TNFAIP3 and TNIP1 polymorphisms with systemic lupus erythematosus risk: A meta-analysis. Gene. 2018;668:155–65.CrossRef Liu X, Qin H, Wu J. Xu J. Association of TNFAIP3 and TNIP1 polymorphisms with systemic lupus erythematosus risk: A meta-analysis. Gene. 2018;668:155–65.CrossRef
25.
go back to reference Hua J, Huang W. Peptidylarginine deiminase 4 -104C/T polymorphism and risk of rheumatoid arthritis: A pooled analysis based on different populations. PloS one. 2018;13:e0193674.CrossRef Hua J, Huang W. Peptidylarginine deiminase 4 -104C/T polymorphism and risk of rheumatoid arthritis: A pooled analysis based on different populations. PloS one. 2018;13:e0193674.CrossRef
26.
go back to reference Lu C, Xu K, Guo H, Peng K, Yang Z, Hao YQ, et al. The relationship of PADI4_94 polymorphisms with the morbidity of rheumatoid arthritis in Caucasian and Asian populations: a meta-analysis and system review. Clin Rheumatol. 2018;37:289–96.CrossRef Lu C, Xu K, Guo H, Peng K, Yang Z, Hao YQ, et al. The relationship of PADI4_94 polymorphisms with the morbidity of rheumatoid arthritis in Caucasian and Asian populations: a meta-analysis and system review. Clin Rheumatol. 2018;37:289–96.CrossRef
27.
go back to reference Ermakov EA, Ivanova SA, Buneva VN, Nevinsky GA. Blood-Derived RNA- and microRNA-Hydrolyzing IgG Antibodies in Schizophrenia Patients. Biochemistry (Mosc). 2018;83:507–26. Ermakov EA, Ivanova SA, Buneva VN, Nevinsky GA. Blood-Derived RNA- and microRNA-Hydrolyzing IgG Antibodies in Schizophrenia Patients. Biochemistry (Mosc). 2018;83:507–26.
28.
go back to reference Pai P, Arathil P, Kotambail A, Nair R, Gupta M, Moily NS, et al. Association of GRIN1, ABCB1, and DRD4 genes and response to antipsychotic drug treatment in schizophrenia. Psychiatr Genet. 2015;25:135–6.CrossRef Pai P, Arathil P, Kotambail A, Nair R, Gupta M, Moily NS, et al. Association of GRIN1, ABCB1, and DRD4 genes and response to antipsychotic drug treatment in schizophrenia. Psychiatr Genet. 2015;25:135–6.CrossRef
29.
go back to reference Rice SR, Niu N, Berman DB, Heston LL, Sobell JL. Identification of single nucleotide polymorphisms (SNPs) and other sequence changes and estimation of nucleotide diversity in coding and flanking regions of the NMDAR1 receptor gene in schizophrenic patients. Mol Psychiatry. 2001;6:274–84.CrossRef Rice SR, Niu N, Berman DB, Heston LL, Sobell JL. Identification of single nucleotide polymorphisms (SNPs) and other sequence changes and estimation of nucleotide diversity in coding and flanking regions of the NMDAR1 receptor gene in schizophrenic patients. Mol Psychiatry. 2001;6:274–84.CrossRef
30.
go back to reference Georgi A, Jamra RA, Klein K, Villela AW, Schumacher J, Becker T, et al. Possible association between genetic variants at the GRIN1 gene and schizophrenia with lifetime history of depressive symptoms in a German sample. Psychiatr Genet. 2007;17:308–10.CrossRef Georgi A, Jamra RA, Klein K, Villela AW, Schumacher J, Becker T, et al. Possible association between genetic variants at the GRIN1 gene and schizophrenia with lifetime history of depressive symptoms in a German sample. Psychiatr Genet. 2007;17:308–10.CrossRef
31.
go back to reference Chanasong R, Thanoi S, Watiktinkorn P, Reynolds GP, Nudmamud-Thanoi S. Genetic variation of GRIN1 confers vulnerability to methamphetamine-dependent psychosis in a Thai population. Neurosci Lett. 2013;551:58–61.CrossRef Chanasong R, Thanoi S, Watiktinkorn P, Reynolds GP, Nudmamud-Thanoi S. Genetic variation of GRIN1 confers vulnerability to methamphetamine-dependent psychosis in a Thai population. Neurosci Lett. 2013;551:58–61.CrossRef
32.
go back to reference Leuba G, Vernay A, Kraftsik R, Tardif E, Riederer BM, Savioz A. Pathological reorganization of NMDA receptors subunits and postsynaptic protein PSD-95 distribution in Alzheimer’s disease. Curr Alzheimer Res. 2014;11:86–96.CrossRef Leuba G, Vernay A, Kraftsik R, Tardif E, Riederer BM, Savioz A. Pathological reorganization of NMDA receptors subunits and postsynaptic protein PSD-95 distribution in Alzheimer’s disease. Curr Alzheimer Res. 2014;11:86–96.CrossRef
33.
go back to reference Wu SL, Wang WF, Shyu HY, Ho YJ, Shieh JC, Fu YP, et al. Association analysis of GRIN1 and GRIN2B polymorphisms and Parkinson’s disease in a hospital-based case-control study. Neurosci Lett. 2010;478:61–5.CrossRef Wu SL, Wang WF, Shyu HY, Ho YJ, Shieh JC, Fu YP, et al. Association analysis of GRIN1 and GRIN2B polymorphisms and Parkinson’s disease in a hospital-based case-control study. Neurosci Lett. 2010;478:61–5.CrossRef
Metadata
Title
Association between polymorphisms in the GRIN1 gene 5′ regulatory region and schizophrenia in a northern Han Chinese population and haplotype effects on protein expression in vitro
Authors
Yong-ping Liu
Mei Ding
Xi-cen Zhang
Yi Liu
Jin-feng Xuan
Jia-xin Xing
Xi Xia
Jun Yao
Bao-jie Wang
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Schizophrenia
Published in
BMC Medical Genetics / Issue 1/2019
Electronic ISSN: 1471-2350
DOI
https://doi.org/10.1186/s12881-019-0757-3

Other articles of this Issue 1/2019

BMC Medical Genetics 1/2019 Go to the issue